Back to Search Start Over

St Andrew's COVID-19 Surgery Safety (StACS) Study: Elective Plastic Surgery, Trauma & Burns

Authors :
Devvrat Katechia
Fady Nasrallah
Michele Turkentine
Anne Tucker
Oliver Counter
Waseem Ullah Khan
Matthew Griffiths
Mark Cornforth
Nigel Tapiwa Mabvuure
Alexander Smith
Nicholas M Pantelides
Loshan Kangesu
Venkat Ramakrishnan
Rui Pinto-Lopes
Jasmine Y M Tang
Mary Morgan
Adela Miranda
Makarand Tare
Helen Palmer
Patricia Rorison
Sally Cowdery
Oscar F Fernandez-Diaz
Alessandro Marasca
Amitabh Thacoor
Reetu Sinha
David G Martin
Naguib El-Muttardi
Claire J. Zweifel
Diana E Zberea
Jo Myers
M.K. Sood
Stratos S. Sofos
Bhagwat Mathur
Miles E Banwell
Aswin Appukuttan
Esther Gathura
Nicola Harris
Sreekanth Raveendran
Carole Watts
Alex Mertic
Amer Hussain
Jan Watts
Swapnil Deelip Dhake
Tracey Sell
Nabil Mopuri
Romulus Constantin Ion Jica
Ben Strong
Fateh Ahmad
Paul Morris
Kallirroi Tzafetta
Niall Martin
Scott Lavender
W.R.M. Hughes
Quillan 'Q' Young Sing
Ben T Smeeton
Adam Sierakowski
Rachel Wiltshire
Odhran Shelley
B.H. Miranda
Tasneem Balgaumwala
Fortune C. Iwuagwu
David E. Barnes
Sheila Prior
Source :
Journal of Plastic, Reconstructive & Aesthetic Surgery
Publication Year :
2020
Publisher :
British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd., 2020.

Abstract

Summary Introduction This study evaluates COVID-19 related patient risk, when undergoing management within one of the largest specialist centres in Europe, which rapidly implemented national COVID-19 safety guidelines. Method A prospective cohort study was undertaken in all patients who underwent surgical (n = 1429) or non-operative (n = 191) management during the UK COVID-19 pandemic peak (April–May 2020); all were evaluated for 30-day COVID-19 related death. A representative sample of elective/trauma/burns patients (surgery group, n = 729) were selected and also sub-analysed within a controlled cohort study design. Comparison was made to a random selection of non-operatively managed (non-operative group, n = 100) or waiting list (control group, n = 250) patients. These groups were prospectively followed-up and telephoned from the end of June (control group) or at 30 days post-first assessment (non-operative group)/post-operatively (surgery group). Results Complex general (9.2%, 136/1483) or regional (5.0%, 74/1483) anaesthesia cases represented 14.2% (210/1483) of operations undertaken. There were no 30-day post-operative (0/1429)/first assessment (0/191) COVID-19 related deaths. Neither the three sub-speciality plastic surgery, or non-operative groups, displayed increases in post-operative/first assessment symptoms in comparison to each other, or to control. The proportion of COVID-19 positive tests were: 7.1% (1/14) (non-operative), 5.9% (2/34) (burns) and 3.0% (3/99) (trauma); there were however no significant differences between these groups, the elective (0%, 0/54) and control (0%, 0/24) groups (p = 0.236). Conclusion We demonstrate that even heterogeneous sub-speciality patient groups, who required operative/non-operative management, did not incur an increased COVID-19 risk compared to each other or to control. These highly encouraging results were achieved with described, rapidly implemented service changes that were tailored to protect each patient group and staff.

Details

Language :
English
ISSN :
18780539 and 17486815
Database :
OpenAIRE
Journal :
Journal of Plastic, Reconstructive & Aesthetic Surgery
Accession number :
edsair.doi.dedup.....ca2e1e979cfc300ded07e2c8df4d6994